BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28434814)

  • 1. Novel protein biomarkers associated with coronary artery disease in statin-treated patients with familial hypercholesterolemia.
    Bos S; Phillips M; Watts GF; Verhoeven AJM; Sijbrands EJG; Ward NC
    J Clin Lipidol; 2017; 11(3):682-693. PubMed ID: 28434814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit.
    Pang J; Poulter EB; Bell DA; Bates TR; Jefferson VL; Hillis GS; Schultz CJ; Watts GF
    J Clin Lipidol; 2015; 9(5):703-8. PubMed ID: 26350818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated subclinical coronary atherosclerosis in patients with familial hypercholesterolemia.
    Neefjes LA; Ten Kate GJ; Alexia R; Nieman K; Galema-Boers AJ; Langendonk JG; Weustink AC; Mollet NR; Sijbrands EJ; Krestin GP; de Feyter PJ
    Atherosclerosis; 2011 Dec; 219(2):721-7. PubMed ID: 22018443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid Biopsy of Extracellular Microvesicles Maps Coronary Calcification and Atherosclerotic Plaque in Asymptomatic Patients With Familial Hypercholesterolemia.
    Chiva-Blanch G; Padró T; Alonso R; Crespo J; Perez de Isla L; Mata P; Badimon L
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):945-955. PubMed ID: 30866660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality.
    Besseling J; Hovingh GK; Huijgen R; Kastelein JJP; Hutten BA
    J Am Coll Cardiol; 2016 Jul; 68(3):252-260. PubMed ID: 27417002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Burnett JR; Bell DA; Bates TR; van Bockxmeer FM; Watts GF
    Int J Cardiol; 2015 Dec; 201():633-8. PubMed ID: 26340131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events.
    D'Erasmo L; Minicocci I; Di Costanzo A; Pigna G; Commodari D; Ceci F; Montali A; Brancato F; Stanca I; Nicolucci A; Ascione A; Galea N; Carbone I; Francone M; Maranghi M; Arca M
    J Am Heart Assoc; 2021 May; 10(9):e018932. PubMed ID: 33890476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, risk factor burden, and severity of coronary artery disease in patients with heterozygous familial hypercholesterolemia hospitalized for an acute myocardial infarction: Data from the French RICO survey.
    Farnier M; Salignon-Vernay C; Yao H; Chague F; Brunel P; Maza M; Brunet D; Bichat F; Beer JC; Cottin Y; Zeller M
    J Clin Lipidol; 2019; 13(4):601-607. PubMed ID: 31324593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
    Davidson M
    Clin Ther; 2013 Aug; 35(8):1247-52. PubMed ID: 23916045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.
    Li S; Wu NQ; Zhu CG; Zhang Y; Guo YL; Gao Y; Li XL; Qing P; Cui CJ; Xu RX; Sun J; Liu G; Dong Q; Li JJ
    Atherosclerosis; 2017 May; 260():67-74. PubMed ID: 28351002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence and clinical characteristics of familial hypercholesterolemia among Chinese patients undergoing coronary angiography due to angina-like chest pain].
    Zhang HW; Li S; Guo YL; Zhu CG; Wu NQ; Liu G; Dong Q; Sun J; Li JJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb; 46(2):104-108. PubMed ID: 29495232
    [No Abstract]   [Full Text] [Related]  

  • 13. CT coronary plaque burden in asymptomatic patients with familial hypercholesterolaemia.
    Neefjes LA; Ten Kate GJ; Rossi A; Galema-Boers AJ; Langendonk JG; Weustink AC; Moelker A; Nieman K; Mollet NR; Krestin GP; Sijbrands EJ; de Feyter PJ
    Heart; 2011 Jul; 97(14):1151-7. PubMed ID: 21565855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suboptimal consideration and management of potential familial hypercholesterolaemia in patients with suspected premature coronary artery disease.
    Yudi M; Omera L; McCubbery N; Dick S; Jayasinghe R; Hamilton-Craig I
    Singapore Med J; 2012 Mar; 53(3):174-8. PubMed ID: 22434290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of coronary atherosclerosis in patients with familial hypercholesterolemia by coronary computed tomography angiography.
    Tada H; Kawashiri MA; Okada H; Teramoto R; Konno T; Yoshimuta T; Sakata K; Nohara A; Inazu A; Kobayashi J; Mabuchi H; Yamagishi M; Hayashi K
    Am J Cardiol; 2015 Mar; 115(6):724-9. PubMed ID: 25618577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of statin treatment on the clinical fate of heterozygous familial hypercholesterolemia.
    Harada-Shiba M; Sugisawa T; Makino H; Abe M; Tsushima M; Yoshimasa Y; Yamashita T; Miyamoto Y; Yamamoto A; Tomoike H; Yokoyama S
    J Atheroscler Thromb; 2010 Jul; 17(7):667-74. PubMed ID: 20534948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating CD45+/CD3+ lymphocyte-derived microparticles map lipid-rich atherosclerotic plaques in familial hypercholesterolaemia patients.
    Suades R; Padró T; Alonso R; López-Miranda J; Mata P; Badimon L
    Thromb Haemost; 2014 Jan; 111(1):111-21. PubMed ID: 24085382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scavenger Receptor LOX1 Genotype Predicts Coronary Artery Disease in Patients With Familial Hypercholesterolemia.
    Paquette M; Dufour R; Baass A
    Can J Cardiol; 2017 Oct; 33(10):1312-1318. PubMed ID: 28941610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carotid plaque burden as a measure of subclinical coronary artery disease in patients with heterozygous familial hypercholesterolemia.
    ten Kate GL; ten Kate GJ; van den Oord SC; Dedic A; Dharampal AS; Nieman K; de Feyter PJ; Sijbrands EJ; van der Steen AF; Schinkel AF
    Am J Cardiol; 2013 May; 111(9):1305-10. PubMed ID: 23411100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Achilles tendon xanthoma and familial hypercholesterolemia in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Kitahara H; Mori N; Saito Y; Nakayama T; Fujimoto Y; Kobayashi Y
    Heart Vessels; 2019 Oct; 34(10):1595-1599. PubMed ID: 30968218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.